femoropopliteal artery
Showing 1 - 25 of 7,364
Femoropopliteal Artery Occlusion, Atherosclerosis Obliterans, Lesion; Vascular Trial in Shanghai (lesion preparation devices,
Recruiting
- Femoropopliteal Artery Occlusion
- +3 more
- lesion preparation devices
- plain old balloon angioplasty
-
Shanghai, Shanghai, ChinaShanghai Pudong Hospital
Jul 22, 2022
Peripheral Arterial Disease Trial in Shanghai (Smart flex stent)
Recruiting
- Peripheral Arterial Disease
- Smart flex stent
-
Shanghai, Shanghai, ChinaRenji Hospital
May 31, 2023
Peripheral Artery Disease Trial in Shanghai (Drug eluting stent, drug coating balloon)
Recruiting
- Peripheral Artery Disease
- Drug eluting stent
- drug coating balloon
-
Shanghai, Shanghai, ChinaChanghai Hospital of Shanghai
Mar 20, 2023
Optimal Stent Selection for the Femoropopliteal Artery
Recruiting
- Femoropopliteal Stenting
- follow-up CTA
-
Omaha, NebraskaUniversity of Nebraska Medical Center
May 17, 2022
Peripheral Artery Disease Trial in Beijing (Sirolimus-eluting balloon catheter, Paclitaxel-eluting balloon catheter)
Recruiting
- Peripheral Artery Disease
- Sirolimus-eluting balloon catheter
- Paclitaxel-eluting balloon catheter
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Aug 17, 2022
Peripheral Arterial Occlusive Disease, Femoropopliteal Artery Occlusion, Femoropopliteal Stenosis Trial in Salzburg (FRAMED
Recruiting
- Peripheral Arterial Occlusive Disease
- +4 more
- FRAMED Infrainguinal Venous Bypass
- Conventional Autologous Bypass
-
Salzburg, AustriaUniversity Hospital of Salzburg, Paracelsus Medical University
Oct 9, 2023
Femoropopliteal Artery Disease Trial in Seoul (Combination therapy of atherectomy and DCB, DCB alone)
Not yet recruiting
- Femoropopliteal Artery Disease
- Combination therapy of atherectomy and DCB
- DCB alone
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 23, 2022
Peripheral Arterial Occlusive Disease, Bypass Complication, Femoropopliteal Artery Occlusion Trial in Salzburg (Balloon
Active, not recruiting
- Peripheral Arterial Occlusive Disease
- +5 more
- Balloon Angioplasty
-
Salzburg, AustriaUniversity Hospital of Salzburg, Paracelsus Medical University
Sep 20, 2023
Peripheral Arterial Disease, Vascular Diseases, Stenosis Trial in Auckland (Efemoral Vascular Scaffold System (EVSS))
Recruiting
- Peripheral Arterial Disease
- +3 more
- Efemoral Vascular Scaffold System (EVSS)
-
Auckland, New ZealandAuckland City Hospital
Mar 31, 2022
Peripheral Arterial Disease Trial (drug-coated balloon)
Not yet recruiting
- Peripheral Arterial Disease
- drug-coated balloon
- (no location specified)
Nov 13, 2022
Peripheral Arterial Disease Trial in Shanghai
Recruiting
- Peripheral Arterial Disease
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Oct 26, 2022
Peripheral Arterial Disease Trial (SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA))
Recruiting
- Peripheral Arterial Disease
- Superficial Femoral Artery Stenosis
- SELUTION SLR™ 018 DEB
- Plain (Uncoated) Balloon Angioplasty (PTA)
-
Davenport, IowaVascular Institute of the Midwest
Dec 19, 2022
Peripheral Artery Disease Trial in Leipzig (Ranger Drug Eluting Balloon, In Pact Drug Eluting Balloon)
Active, not recruiting
- Peripheral Artery Disease
- Ranger Drug Eluting Balloon
- In Pact Drug Eluting Balloon
-
Leipzig, Saxony, GermanyUniversity Clinic Leipzig
Dec 13, 2021
Femoropopliteal Artery Occlusion Trial in Chengdu (Endovascular Therapy)
Recruiting
- Femoropopliteal Artery Occlusion
- Endovascular Therapy
-
Chengdu, Sichuan, ChinaChunshuihe
Apr 2, 2022
Drug-coated Balloon, Femoropopliteal Artery Occlusion, Angioplasty Trial in China (Drug-coated Balloon)
Recruiting
- Drug-coated Balloon
- +2 more
- Drug-coated Balloon
-
Wuhan, Hubei, China
- +8 more
Oct 30, 2022
Drug-coated Balloon Catheter Trial in Dijon (6-minute walk test, WIQ functional questionnaire, quality of life questionnaires
Recruiting
- Drug-coated Balloon Catheter
- 6-minute walk test
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Feb 28, 2022
BD Sirolimus Drug Coated Catheter for Treatment of
Recruiting
- Peripheral Arterial Disease
- +2 more
- BD™ Sirolimus Drug Coated Balloon Catheter angioplasty
-
Grafton, Auckland, New ZealandAuckland City Hospital
Nov 10, 2022
Endovascular Therapies in Chronic Femoropopliteal Occlusive
Recruiting
- Femoropopliteal Artery Occlusion
-
Hangzhou, Zhejiang, ChinaThe First Affliated Hospital, Zhejiang University, School of Med
Dec 3, 2021
Intravascular Lithotripsy and Drug Eluting Stent Deployment for
Recruiting
- Peripheral Arterial Disease
- +2 more
- Peripheral lithotripsy system (Shockwave Medical)
-
Arnsberg, Germany
- +3 more
Nov 14, 2022
The DETECT Project
Recruiting
- Femoropopliteal Atheromatous Lesions
- Lower limb artery revascularization with paclitaxel-eluting device
-
Whole Country, FranceFrance
Apr 20, 2022
Peripheral Artery Disease Trial in New York (Percutaneous Revascularization of the Femoropopliteal Arteries using a DAS,
Active, not recruiting
- Peripheral Artery Disease
- Percutaneous Revascularization of the Femoropopliteal Arteries using a DAS
- Percutaneous Revascularization of the Femoropopliteal Arteries using a OAS device
-
New York, New YorkNew York University School of Medicine
Jul 26, 2022
Femoropopliteal Disease Trial in Korea, Republic of (intravascular ultrasound-guided group, angiography-guided group)
Recruiting
- Femoropopliteal Disease
- intravascular ultrasound-guided group
- angiography-guided group
-
Busan, Korea, Republic of
- +6 more
Apr 6, 2023
Peripheral Artery Disease Trial in Shanghai (Orchid 035 DCB Catheter, POBA Catheter)
Recruiting
- Peripheral Artery Disease
- Orchid 035 DCB Catheter
- POBA Catheter
-
Shanghai, Shanghai, China
- +2 more
Feb 13, 2022
Superficial Femoral Artery Stenosis, Claudication, Ischemic Leg Trial in Lille (femoropopliteal revascularization for TASC C or
Recruiting
- Superficial Femoral Artery Stenosis
- +2 more
- femoropopliteal revascularization for TASC C or TASC D lesion
-
Lille, FranceInsitut Coeur-Poumon, CHU
May 23, 2022
Peripheral Arterial Disease Trial in Worldwide (Passeo-18 Lux treatment group, IN.PACT Admiral treatment group)
Active, not recruiting
- Peripheral Arterial Disease
- Passeo-18 Lux treatment group
- IN.PACT Admiral treatment group
-
Graz, Austria
- +14 more
Sep 7, 2021